Lyell Immunopharma, Inc.

-

Assets, Funds, Holdings

Home | Sign Up | Log In
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Lyell Immunopharma, Inc.
CIK #0001806952
EDGAR Form CIK 2011 - 2025
10-K [0001806952]
10-Q [0001806952]
3 [0001806952]
4 [0001806952]
8-K [0001806952]
D [0001806952]
SC 13G [0001806952]
Form 13D/13G Filer Form 13D/13G Subject Filed
Explore Investments Llc/De Lyell Immunopharma Inc [2025-08-19]
Gates Frontier LLC Lyell Immunopharma Inc [2025-08-01]
Foresite Capital Fund IV LP Lyell Immunopharma Inc [2024-10-31]
BlackRock Inc Lyell Immunopharma Inc [2024-01-29]
Vanguard Group Inc Lyell Immunopharma Inc [2023-02-09]
MWG Management Ltd Lyell Immunopharma Inc [2022-02-14]
Arch Venture Fund IX LP Lyell Immunopharma Inc [2022-02-14]
Newton PTC Ltd Lyell Immunopharma Inc [2022-02-14]
Foresite Capital Fund IV LP Lyell Immunopharma Inc [2022-02-11]
GlaxoSmithKline PLC Lyell Immunopharma Inc [2022-02-10]
Form 3/4/5 Subject 2011 - 2025
Lyell Immunopharma, Inc.
Newton Charles W.
Seely Lynn
Hill Stephen J.
Lee Gary K.
Crandell Keith
Gillis Steven
ARCH Venture Partners XIII, LLC
Berns Paul L
Nelsen Robert
View All
Terms | Privacy | Guide
tony@aum13f.com